Impact of Epicatechin on the Procoagulant Activities of Microparticles

Microparticles play a role in cardiovascular disease pathology. The flavanol-like epicatechin is increasingly considered due to its cardioprotective effects. The aim of this study was to investigate the impact of epicatechin on microparticle generation, phenotype and procoagulant properties. Plasma...

Full description

Bibliographic Details
Main Authors: Thomas Sinegre, Dragan Milenkovic, Céline Bourgne, Dorian Teissandier, Yosra Nasri, Louis-Thomas Dannus, Christine Morand, Aurélien Lebreton
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/12/10/2935
id doaj-ef279c100b4048c99610f3766b4e54f1
record_format Article
spelling doaj-ef279c100b4048c99610f3766b4e54f12020-11-25T03:28:25ZengMDPI AGNutrients2072-66432020-09-01122935293510.3390/nu12102935Impact of Epicatechin on the Procoagulant Activities of MicroparticlesThomas Sinegre0Dragan Milenkovic1Céline Bourgne2Dorian Teissandier3Yosra Nasri4Louis-Thomas Dannus5Christine Morand6Aurélien Lebreton7UNH Unité de Nutrition Humaine, Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement, Université Clermont Auvergne, 63000 Clermont-Ferrand, FranceUNH Unité de Nutrition Humaine, Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement, Université Clermont Auvergne, 63000 Clermont-Ferrand, FranceCHU Clermont-Ferrand, Service d’Hématologie Biologique, 63000 Clermont-Ferrand, FranceUNH Unité de Nutrition Humaine, Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement, Université Clermont Auvergne, 63000 Clermont-Ferrand, FranceCHU Clermont-Ferrand, Service d’Hématologie Biologique, 63000 Clermont-Ferrand, FranceCHU Clermont-Ferrand, Service d’Hématologie Biologique, 63000 Clermont-Ferrand, FranceUNH Unité de Nutrition Humaine, Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement, Université Clermont Auvergne, 63000 Clermont-Ferrand, FranceUNH Unité de Nutrition Humaine, Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement, Université Clermont Auvergne, 63000 Clermont-Ferrand, FranceMicroparticles play a role in cardiovascular disease pathology. The flavanol-like epicatechin is increasingly considered due to its cardioprotective effects. The aim of this study was to investigate the impact of epicatechin on microparticle generation, phenotype and procoagulant properties. Plasma samples from 15 healthy subjects were incubated with increasing concentrations of epicatechin (1 to 100 μM). Then, the expression of glycoprotein IIb, phosphatidylserine (PS), glycoprotein Ib (GPIb) and P-selectin was assessed by flow cytometry analysis after (or not) platelet stimulation. Microparticle procoagulant activity was determined using Zymuphen<sup>TM</sup> MP and Zymuphen<sup>TM</sup> MP-TF for phospholipid and tissue factor content, and with thrombin generation (TG) assays for procoagulant function. Platelet microparticles that express GPIb (/µL) decreased from 20,743 ± 24,985 (vehicle) to 14,939 ± 14,333 (<i>p</i> = 0.6), 21,366 ± 16,949 (<i>p</i> = 0.9) and 15,425 ± 9953 (<i>p</i> < 0.05) in samples incubated with 1, 10 and 100 µM epicatechin, respectively. Microparticle concentration (nM PS) decreased from 5.6 ± 2.0 (vehicle) to 5.1 ± 2.2 (<i>p</i> = 0.5), 4.5 ± 1.5 (<i>p</i> < 0.05) and 4.7 ± 2.0 (<i>p</i> < 0.05) in samples incubated with 1, 10 and 100µM epicatechin, respectively. Epicatechin had no impact on tissue factor-positive microparticle concentration. Epicatechin decreased TG (endogenous thrombin potential, nM.min) from 586 ± 302 to 509 ± 226 (<i>p</i> = 0.3), 512 ± 270 (<i>p</i> = 0.3) and 445 ± 283 (<i>p</i> < 0.05). These findings indicate that epicatechin affects microparticle release, phenotype and procoagulant properties.https://www.mdpi.com/2072-6643/12/10/2935cardiovascular diseasecoagulationepicatechinhemostasismicroparticles
collection DOAJ
language English
format Article
sources DOAJ
author Thomas Sinegre
Dragan Milenkovic
Céline Bourgne
Dorian Teissandier
Yosra Nasri
Louis-Thomas Dannus
Christine Morand
Aurélien Lebreton
spellingShingle Thomas Sinegre
Dragan Milenkovic
Céline Bourgne
Dorian Teissandier
Yosra Nasri
Louis-Thomas Dannus
Christine Morand
Aurélien Lebreton
Impact of Epicatechin on the Procoagulant Activities of Microparticles
Nutrients
cardiovascular disease
coagulation
epicatechin
hemostasis
microparticles
author_facet Thomas Sinegre
Dragan Milenkovic
Céline Bourgne
Dorian Teissandier
Yosra Nasri
Louis-Thomas Dannus
Christine Morand
Aurélien Lebreton
author_sort Thomas Sinegre
title Impact of Epicatechin on the Procoagulant Activities of Microparticles
title_short Impact of Epicatechin on the Procoagulant Activities of Microparticles
title_full Impact of Epicatechin on the Procoagulant Activities of Microparticles
title_fullStr Impact of Epicatechin on the Procoagulant Activities of Microparticles
title_full_unstemmed Impact of Epicatechin on the Procoagulant Activities of Microparticles
title_sort impact of epicatechin on the procoagulant activities of microparticles
publisher MDPI AG
series Nutrients
issn 2072-6643
publishDate 2020-09-01
description Microparticles play a role in cardiovascular disease pathology. The flavanol-like epicatechin is increasingly considered due to its cardioprotective effects. The aim of this study was to investigate the impact of epicatechin on microparticle generation, phenotype and procoagulant properties. Plasma samples from 15 healthy subjects were incubated with increasing concentrations of epicatechin (1 to 100 μM). Then, the expression of glycoprotein IIb, phosphatidylserine (PS), glycoprotein Ib (GPIb) and P-selectin was assessed by flow cytometry analysis after (or not) platelet stimulation. Microparticle procoagulant activity was determined using Zymuphen<sup>TM</sup> MP and Zymuphen<sup>TM</sup> MP-TF for phospholipid and tissue factor content, and with thrombin generation (TG) assays for procoagulant function. Platelet microparticles that express GPIb (/µL) decreased from 20,743 ± 24,985 (vehicle) to 14,939 ± 14,333 (<i>p</i> = 0.6), 21,366 ± 16,949 (<i>p</i> = 0.9) and 15,425 ± 9953 (<i>p</i> < 0.05) in samples incubated with 1, 10 and 100 µM epicatechin, respectively. Microparticle concentration (nM PS) decreased from 5.6 ± 2.0 (vehicle) to 5.1 ± 2.2 (<i>p</i> = 0.5), 4.5 ± 1.5 (<i>p</i> < 0.05) and 4.7 ± 2.0 (<i>p</i> < 0.05) in samples incubated with 1, 10 and 100µM epicatechin, respectively. Epicatechin had no impact on tissue factor-positive microparticle concentration. Epicatechin decreased TG (endogenous thrombin potential, nM.min) from 586 ± 302 to 509 ± 226 (<i>p</i> = 0.3), 512 ± 270 (<i>p</i> = 0.3) and 445 ± 283 (<i>p</i> < 0.05). These findings indicate that epicatechin affects microparticle release, phenotype and procoagulant properties.
topic cardiovascular disease
coagulation
epicatechin
hemostasis
microparticles
url https://www.mdpi.com/2072-6643/12/10/2935
work_keys_str_mv AT thomassinegre impactofepicatechinontheprocoagulantactivitiesofmicroparticles
AT draganmilenkovic impactofepicatechinontheprocoagulantactivitiesofmicroparticles
AT celinebourgne impactofepicatechinontheprocoagulantactivitiesofmicroparticles
AT dorianteissandier impactofepicatechinontheprocoagulantactivitiesofmicroparticles
AT yosranasri impactofepicatechinontheprocoagulantactivitiesofmicroparticles
AT louisthomasdannus impactofepicatechinontheprocoagulantactivitiesofmicroparticles
AT christinemorand impactofepicatechinontheprocoagulantactivitiesofmicroparticles
AT aurelienlebreton impactofepicatechinontheprocoagulantactivitiesofmicroparticles
_version_ 1724584355057106944